Acute myeloid leukaemia+1
Not recruitingStudy on Midostaurin and Decitabine for Adults with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Who Are Unfit for Intensive Treatment
Study on Midostaurin and Decitabine for Adults with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Who Are Unfit for Intensive Treatment
- Disease:Acute myeloid leukaemiaMyelodysplastic syndrome
- Substances:DecitabineMidostaurin
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Decitabine
- Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting






